57 related articles for article (PubMed ID: 11410872)
1. Kinetics of cytokine expression in melanoma metastases classifies immune responsiveness.
Mocellin S; Ohnmacht GA; Wang E; Marincola FM
Int J Cancer; 2001 Jul; 93(2):236-42. PubMed ID: 11410872
[TBL] [Abstract][Full Text] [Related]
2. Immune response against human primary malignant melanoma: a distinct cytokine mRNA profile associated with spontaneous regression.
Wagner SN; Schultewolter T; Wagner C; Briedigkeit L; Becker JC; Kwasnicka HM; Goos M
Lab Invest; 1998 May; 78(5):541-50. PubMed ID: 9605179
[TBL] [Abstract][Full Text] [Related]
3. Addition of histamine to interleukin 2 treatment augments type 1 T-cell responses in patients with melanoma in vivo: immunologic results from a randomized clinical trial of interleukin 2 with or without histamine (MP 104).
Asemissen AM; Scheibenbogen C; Letsch A; Hellstrand K; Thorén F; Gehlsen K; Schmittel A; Thiel E; Keilholz U
Clin Cancer Res; 2005 Jan; 11(1):290-7. PubMed ID: 15671558
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of transforming growth factor beta 1 and interleukin 10 in progressing and regressing areas of primary melanoma.
Conrad CT; Ernst NR; Dummer W; Bröcker EB; Becker JC
J Exp Clin Cancer Res; 1999 Jun; 18(2):225-32. PubMed ID: 10464712
[TBL] [Abstract][Full Text] [Related]
5. Immunization with Melan-A peptide-pulsed peripheral blood mononuclear cells plus recombinant human interleukin-12 induces clinical activity and T-cell responses in advanced melanoma.
Peterson AC; Harlin H; Gajewski TF
J Clin Oncol; 2003 Jun; 21(12):2342-8. PubMed ID: 12805336
[TBL] [Abstract][Full Text] [Related]
6. Interaction with fibronectin regulates cytokine gene expression in human melanoma cells.
Lupetti R; Mortarini R; Panceri P; Sensi M; Anichini A
Int J Cancer; 1996 Mar; 66(1):110-6. PubMed ID: 8608953
[TBL] [Abstract][Full Text] [Related]
7. Lymphocyte activation as cytokine gene expression and secretion is related to the porcine reproductive and respiratory syndrome virus (PRRSV) isolate after in vitro homologous and heterologous recall of peripheral blood mononuclear cells (PBMC) from pigs vaccinated and exposed to natural infection.
Ferrari L; Martelli P; Saleri R; De Angelis E; Cavalli V; Bresaola M; Benetti M; Borghetti P
Vet Immunol Immunopathol; 2013 Feb; 151(3-4):193-206. PubMed ID: 23228653
[TBL] [Abstract][Full Text] [Related]
8. Metastatic lesions with and without interleukin-18-dependent genes in advanced-stage melanoma patients.
Crende O; Sabatino M; Valcárcel M; Carrascal T; Riestra P; López-Guerrero JA; Nagore E; Mandruzzato S; Wang E; Marincola FM; Vidal-Vanaclocha F
Am J Pathol; 2013 Jul; 183(1):69-82. PubMed ID: 23707237
[TBL] [Abstract][Full Text] [Related]
9. Vaccination with IL-12 gene-modified autologous melanoma cells: preclinical results and a first clinical phase I study.
Sun Y; Jurgovsky K; Möller P; Alijagic S; Dorbic T; Georgieva J; Wittig B; Schadendorf D
Gene Ther; 1998 Apr; 5(4):481-90. PubMed ID: 9614572
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of immune response during immunotherapy.
Panelli MC; Nagorsen D; Wang E; Monsurro V; Jin P; Katia Z; Smith K; Ngalame Y; Marincola FM
Yonsei Med J; 2004 Jun; 45 Suppl():15-7. PubMed ID: 15250044
[TBL] [Abstract][Full Text] [Related]
11. Clinical and immunological evaluation of patients with metastatic melanoma undergoing immunization with the HLA-Cw*0702-associated epitope MAGE-A12:170-178.
Bettinotti MP; Panelli MC; Ruppe E; Mocellin S; Phan GQ; White DE; Marincola FM
Int J Cancer; 2003 Jun; 105(2):210-6. PubMed ID: 12673681
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic vaccination against metastatic carcinoma by expression-modulated and immunomodified autologous tumor cells: a first clinical phase I/II trial.
Wittig B; Märten A; Dorbic T; Weineck S; Min H; Niemitz S; Trojaneck B; Flieger D; Kruopis S; Albers A; Löffel J; Neubauer A; Albers P; Müller S; Sauerbruch T; Bieber T; Huhn D; Schmidt-Wolf IG
Hum Gene Ther; 2001 Feb; 12(3):267-78. PubMed ID: 11177563
[TBL] [Abstract][Full Text] [Related]
13. Desensitization of melanoma cells to autocrine TGF-beta isoforms.
Krasagakis K; Krüger-Krasagakes S; Fimmel S; Eberle J; Thölke D; von der Ohe M; Mansmann U; Orfanos CE
J Cell Physiol; 1999 Feb; 178(2):179-87. PubMed ID: 10048582
[TBL] [Abstract][Full Text] [Related]
14. Immunization of HLA-A2+ melanoma patients with MAGE-3 or MelanA peptide-pulsed autologous peripheral blood mononuclear cells plus recombinant human interleukin 12.
Gajewski TF; Fallarino F; Ashikari A; Sherman M
Clin Cancer Res; 2001 Mar; 7(3 Suppl):895s-901s. PubMed ID: 11300489
[TBL] [Abstract][Full Text] [Related]
15. Quantitative analysis of melanoma-induced cytokine-mediated immunosuppression in melanoma sentinel nodes.
Lee JH; Torisu-Itakara H; Cochran AJ; Kadison A; Huynh Y; Morton DL; Essner R
Clin Cancer Res; 2005 Jan; 11(1):107-12. PubMed ID: 15671534
[TBL] [Abstract][Full Text] [Related]
16. Analysis and characterization of antitumor T-cell response after administration of dendritic cells loaded with allogeneic tumor lysate to metastatic melanoma patients.
Bercovici N; Haicheur N; Massicard S; Vernel-Pauillac F; Adotevi O; Landais D; Gorin I; Robert C; Prince HM; Grob JJ; Leccia MT; Lesimple T; Wijdenes J; Bartholeyns J; Fridman WH; Salcedo M; Ferries E; Tartour E
J Immunother; 2008 Jan; 31(1):101-12. PubMed ID: 18157017
[TBL] [Abstract][Full Text] [Related]
17. Differential cytokine mRNA expression in mice after oral exposure to the trichothecene vomitoxin (deoxynivalenol): dose response and time course.
Zhou HR; Yan D; Pestka JJ
Toxicol Appl Pharmacol; 1997 Jun; 144(2):294-305. PubMed ID: 9194413
[TBL] [Abstract][Full Text] [Related]
18. Prospective molecular profiling of melanoma metastases suggests classifiers of immune responsiveness.
Wang E; Miller LD; Ohnmacht GA; Mocellin S; Perez-Diez A; Petersen D; Zhao Y; Simon R; Powell JI; Asaki E; Alexander HR; Duray PH; Herlyn M; Restifo NP; Liu ET; Rosenberg SA; Marincola FM
Cancer Res; 2002 Jul; 62(13):3581-6. PubMed ID: 12097256
[TBL] [Abstract][Full Text] [Related]
19. Herpes simplex virus type 1 alters transcript levels of tumor necrosis factor-alpha and interleukin-6 in retinal glial cells.
Drescher KM; Whittum-Hudson JA
Invest Ophthalmol Vis Sci; 1996 Oct; 37(11):2302-12. PubMed ID: 8843914
[TBL] [Abstract][Full Text] [Related]
20. Endothelial expression of vascular cell adhesion molecule-1 correlates with metastatic pattern in spontaneous melanoma.
Langley RR; Carlisle R; Ma L; Specian RD; Gerritsen ME; Granger DN
Microcirculation; 2001 Oct; 8(5):335-45. PubMed ID: 11687945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
